Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
2.14
8 yrs 10 m
0.25%
1,208.05 Crs
0.25% on or before 30D
Large Growth
6.6
SIP 100 & Lumpsum 5000
NA
Meeta Shetty,Rajat Srivastava
Investors understand that their principal will be at very high risk